Novel TEM-type extended-spectrum β-lactamase, TEM-134, in a Citrobacter koseri clinical isolate

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1564-1566

  Perilli, Mariagrazia ^a   Mugnaioli, Claudia ^b   Luzzaro, Francesco ^c   Fiore, Marianna ^a   Stefani, Stefania ^d   Rossolini, Gian Maria ^b   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBENICILLIN; CEFAZOLIN; CEFEPIME; CEFOTAXIMASE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PLASMID DNA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEM 134 BETA LACTAMASE; TICARCILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CITROBACTER KOSERI; DNA PROBE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URINE CULTURE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CITROBACTER KOSERI; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 16244362017     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1564-1566.2005     Document Type: Article

References (17)

1. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
2. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
4. Cantu, C., and T. Palzkill. 1998. The role of residue 238 of TEM-1 β-lactamase in the hydrolysis of extended-spectrum antibiotics. J. Biol. Chem. 273:26603-26609.
5. Chanal, C. M., D. L. Sirot, A. Petit, R. Labia, A. Morand, J. L. Sirot, and R. A. Cluzel. 1989. Multiplicity of TEM-derived β-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob. Agents Chemother. 33:1915-1920.
6. Huang, W., and T. Palzkill. 1997. A natural polymorphism in β-lactamase is a global suppressor. Proc. Natl. Acad. Sci. USA 94:8801-8806.
7. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
8. National Committee for Clinical Laboratory Standards. 2003 Performance standards for antimicrobial susceptibility testing; 13th informational supplement. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Oliva, B., M. C. Marinucci, G. Amicosante, A. Oratore, and P. M. Bennet. 1987. Citrobacter diversus ULA27 produces two forms of a chromosomal β-lactamase. J. Antimicrob. Chemother. 20:23-35.
10. Pagani, L., E. Mantengoli, R. Migliavacca, E. Nucleo, S. Pollini, M. Spalla, R. Daturi, E. Romero, and G. M. Rossolini. 2004. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase in northern Italy. J. Clin. Microbiol. 42:2523-2529.
11. Patterson, D. L., K. M. Hujer, A. M. Hujer, B. Yeiser, L. B. Rice, and R. A. Bonomo. 2003. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.
12. Perilli, M., E. Dell'Amico, B. Segatore, M. R. De Massis, C. Bianchi, F. Luzzaro, G. M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40:611-614.
13. Quinteros, M., M. Radice, N. Gardella, M. M. Rodriguez, N Costa, D. Korbenfeld, E. Couto, G. Gutkind, and the Microbiology Study Group. 2003. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals. Antimicrob. Agents Chemother. 47:2864-2867.
14. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Sougakoff, W., S. Goussard, and P. Courvalin. 1988. The TEM-3 β-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiol. Lett. 56:343-348.
16. Spanu, T., F. Luzzaro, M. Perilli, G. Amicosante, A. Toniolo, G. Fadda, and The Italian ESβL Study Group. 2002. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob. Agents Chemother. 46:196-202.
17. Tsao, S. G., C. F. Brunk, and R. E. Pearlman. 1983. Hybridization of nucleic acids directly in agarose gels. Anal. Biochem. 131:365-372.